PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Its AISight® platform is a cloud-native enterprise workflow solution used by leading laboratories and research centers to power digital pathology workflows and AI applications, serving as a central hub for case management, image management, and artificial intelligence tools. The company collaborates with healthcare organizations, pathology laboratories, and biopharmaceutical companies to support precision medicine and pathology digitization initiatives.
Cyborg Score Rationale
PathAI holds a leading market position in AI-powered digital pathology with comprehensive end-to-end solutions spanning diagnostics, drug development, and clinical research. The company demonstrates strong technical innovation through multimodal AI models and has attracted substantial capital and strategic partnerships. However, the market remains emerging and competitive, limiting the highest confidence tier.
Top Insights
PathAI is headquartered in Boston, MA and operates a CAP/CLIA-certified laboratory in Memphis, TN, enabling both software deployment and wet-lab service delivery.
As of April 2026, PathAI advanced to multimodal pathology models combining visual and language features, achieving ~4-6% improvement in Dermatopathology and ~8-10% improvement in GI pathology
PathAI is named as a leader among 15 other companies in digital pathology, including Philips, Proscia, and Ibex
PathAI's AI-powered models are trained and validated with data from more than 15 million pathologist annotations
Named Competitors
Ibex — AI-based cancer diagnostics for pathology assistance
Proscia — Digital pathology software for healthcare and life sciences
Paige — AI-powered pathology analytics
Recent Developments
(April 2026) Launched multimodal pathology models combining vision and language with PLUTO-4 foundation model for improved disease classification
(May 2026) Announced AISight® Dx v2.19 with multi-algorithm support and enhanced reporting workflows
(May 2026) Joined Massachusetts AI Coalition to advance AI ecosystem in healthcare and life sciences
Open the full interactive PathAI, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.